MedTrace Logo

The Use of Iron Therapy for Patients With Anemia After Caesarean Section

NCT01975272 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2022-08-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether oral or intravenous iron is effective in the treatment of anaemia (iron-poor blood) after caesarean section.

Conditions

  • Postoperative Anaemia

Interventions

DRUG

Ferinject

DRUG

Ferrous fumarate

DRUG

Placebo for ferrous fumarate

DRUG

Placebo for ferinject

Sponsors & Collaborators

  • Vifor Pharma

    collaborator INDUSTRY

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Roy Kruitwagen · Maastricht University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-02
Primary Completion
2018-05-17
Completion
2018-06-21

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01975272 on ClinicalTrials.gov